Clinical Trials List
Protocol Number192024-056
2012-01-31 - 2015-03-30
Phase III
Terminated2
-
Trial Applicant
ALLERGAN PHARMACEUTICALS TAIWAN CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
84 participants
